D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Snap
SNAP
|
$436M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
$373M |
| 3 |
Fidelity National Information Services
FIS
|
$351M |
| 4 |
Cisco
CSCO
|
$350M |
| 5 |
Lockheed Martin
LMT
|
$348M |
Top Sells
| 1 |
Tesla
TSLA
|
$771M |
| 2 |
Advanced Micro Devices
AMD
|
$593M |
| 3 |
Boeing
BA
|
$590M |
| 4 |
Lowe's Companies
LOW
|
$519M |
| 5 |
Alibaba
BABA
|
$352M |
Sector Composition
| 1 | Technology | 19.42% |
| 2 | Consumer Discretionary | 14.02% |
| 3 | Healthcare | 12.06% |
| 4 | Communication Services | 9.1% |
| 5 | Financials | 8.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
FTCH
76
DELISTED
Farfetch Limited Class A Ordinary Shares
FTCH
| $192M | 0.17% |
3,007,351
+410,095
| +16% | +$26.2M |
|
|
NVRO
77
DELISTED
NEVRO CORP.
NVRO
| $190M | 0.17% |
1,099,450
-157,327
| -13% | -$27.2M |
|
|
SAGE
78
DELISTED
Sage Therapeutics
SAGE
| $190M | 0.17% |
2,194,887
-268,179
| -11% | -$23.2M |
|
79
Target
TGT
$41.7B
| $187M | 0.17% |
1,058,357
-107,998
| -9% | -$19.1M |
|
80
Bank of America
BAC
$373B
| $186M | 0.17% |
6,152,945
-1,034,785
| -14% | -$31.4M |
|
81
NextEra Energy, Inc.
NEE
$148B
| $184M | 0.16% |
2,390,137
+1,808,235
| +311% | +$140M |
|
82
Ametek
AME
$42.4B
| $182M | 0.16% |
1,507,849
-124,661
| -8% | -$15.1M |
|
83
Dominion Energy
D
$50.4B
| $181M | 0.16% |
2,411,450
+2,255,332
| +1,445% | +$170M |
|
84
Cardinal Health
CAH
$35.9B
| $176M | 0.16% |
3,294,220
+423,944
| +15% | +$22.7M |
|
85
Crown Castle
CCI
$42.9B
| $173M | 0.15% |
1,084,588
-472,717
| -30% | -$75.3M |
|
|
PLAN
86
DELISTED
Anaplan, Inc.
PLAN
| $172M | 0.15% |
2,387,505
-113,200
| -5% | -$8.13M |
|
87
Abbott
ABT
$229B
| $171M | 0.15% |
1,564,933
+658,128
| +73% | +$72.1M |
|
88
TransUnion
TRU
$17.2B
| $170M | 0.15% |
1,713,565
-305,199
| -15% | -$30.3M |
|
89
Adobe
ADBE
$147B
| $169M | 0.15% |
338,747
+227,669
| +205% | +$114M |
|
|
HZNP
90
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $169M | 0.15% |
2,303,746
-735,867
| -24% | -$53.8M |
|
91
Biogen
BIIB
$20.9B
| $168M | 0.15% |
687,793
+319,901
| +87% | +$78.3M |
|
92
UnitedHealth
UNH
$276B
| $168M | 0.15% |
480,183
-169,262
| -26% | -$59.4M |
|
93
Exxon Mobil
XOM
$477B
| $168M | 0.15% |
4,068,668
+1,642,824
| +68% | +$67.7M |
|
94
TJX Companies
TJX
$155B
| $167M | 0.15% |
2,450,482
+83,953
| +4% | +$5.73M |
|
95
Schlumberger
SLB
$52.3B
| $166M | 0.15% |
7,581,620
+4,401,880
| +138% | +$96.1M |
|
96
Amicus Therapeutics
FOLD
$2.43B
| $163M | 0.15% |
7,079,596
-264,668
| -4% | -$6.11M |
|
97
Colgate-Palmolive
CL
$67.4B
| $161M | 0.14% |
1,877,695
-207,704
| -10% | -$17.8M |
|
98
Monster Beverage
MNST
$61.8B
| $160M | 0.14% |
1,730,832
+195,895
| +13% | +$18.1M |
|
99
Qualcomm
QCOM
$171B
| $156M | 0.14% |
1,025,551
-865,525
| -46% | -$132M |
|
100
SPDR S&P 500 ETF Trust
SPY
$657B
| $153M | 0.14% |
409,948
+37,838
| +10% | +$14.1M |
|